Total Payments
$4,192
2024 Payments
$1,082
Companies
32
Transactions
174
Medicare Patients
2,044
Medicare Billing
$500,898
Payment Breakdown by Category
Food & Beverage$4,158 (99.2%)
Education$33.56 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,158 | 172 | 99.2% |
| Education | $33.56 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Travere Therapeutics, Inc. | $384.87 | 19 | $0 (2024) |
| Amgen Inc. | $368.95 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $349.80 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $311.73 | 16 | $0 (2024) |
| Abbott Laboratories | $245.91 | 2 | $0 (2021) |
| Vifor Pharma, Inc. | $210.38 | 10 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $208.04 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $185.79 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $166.22 | 8 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $162.09 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,082 | 52 | Novartis Pharmaceuticals Corporation ($286.16) |
| 2023 | $1,022 | 48 | Travere Therapeutics, Inc. ($219.92) |
| 2022 | $773.69 | 40 | AstraZeneca Pharmaceuticals LP ($131.12) |
| 2021 | $680.29 | 25 | Abbott Laboratories ($122.94) |
| 2020 | $118.87 | 1 | PFIZER INC. ($118.87) |
| 2019 | $373.09 | 6 | Amgen Inc. ($123.30) |
| 2018 | $142.43 | 2 | Abbott Laboratories ($122.97) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Catheter Lock Solution | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Hyperkalemia | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $33.57 | General |
| 10/23/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $29.79 | General |
| 09/24/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Nephrology | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Hyperkalemia | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: DIABETES | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardio-renal | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.04 | General |
| 07/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.42 | General |
| 07/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: Rare Disease | ||||||
| 07/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 807 | 1,706 | $567,892 | $203,154 |
| 2022 | 14 | 769 | 1,739 | $530,564 | $199,175 |
| 2021 | 12 | 468 | 932 | $234,714 | $98,569 |
Total Patients
2,044
Total Services
4,377
Medicare Billing
$500,898
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 49 | 276 | $191,820 | $71,568 | 37.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 151 | 302 | $70,060 | $26,945 | 38.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 18 | 123 | $71,925 | $26,561 | 36.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 371 | $62,560 | $21,745 | 34.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 95 | 101 | $38,885 | $13,114 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 140 | $36,832 | $12,113 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 155 | $27,291 | $8,248 | 30.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 23 | $13,405 | $4,948 | 36.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 26 | $14,750 | $4,063 | 27.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 47 | 73 | $12,620 | $3,936 | 31.2% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 25 | 61 | $10,960 | $3,892 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $10,604 | $3,866 | 36.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 22 | $6,180 | $2,156 | 34.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 61 | 278 | $193,210 | $73,194 | 37.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 132 | 344 | $68,800 | $26,415 | 38.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 130 | 432 | $60,480 | $23,291 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 104 | 117 | $45,045 | $17,220 | 38.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 19 | 79 | $45,425 | $17,111 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 130 | $32,257 | $10,966 | 34.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 27 | 34 | $19,550 | $7,638 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 117 | $20,352 | $6,897 | 33.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 56 | 99 | $14,355 | $5,377 | 37.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 19 | $10,165 | $3,152 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,346 | $2,644 | 36.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 11 | 32 | $5,120 | $2,077 | 40.6% |
About Muna Hale
Muna Hale is a Nephrology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2016. The National Provider Identifier (NPI) number assigned to this provider is 1801257134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Muna Hale has received a total of $4,192 in payments from pharmaceutical and medical device companies, with $1,082 received in 2024. These payments were reported across 174 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,158).
As a Medicare-enrolled provider, Hale has provided services to 2,044 Medicare beneficiaries, totaling 4,377 services with total Medicare billing of $500,898. Data is available for 3 years (2021–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Tulsa, OK
- Active Since 03/15/2016
- Last Updated 06/29/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801257134
Products in Payments
- Veltassa (Drug) $210.38
- LUPKYNIS (Drug) $208.04
- Kerendia (Drug) $185.79
- JYNARQUE (Drug) $166.22
- FARXIGA (Drug) $164.28
- Fabhalta (Drug) $163.98
- RAYALDEE (Drug) $162.09
- LOKELMA (Drug) $147.45
- JARDIANCE (Drug) $144.54
- Prolia (Biological) $142.76
- Parsabiv (Drug) $139.96
- NXSTAGE SYSTEM ONE (Device) $131.35
- ULTOMIRIS (Biological) $124.88
- CardioMEMS HF System (Device) $122.97
- Fortify Assura, Ellipse ICD (Device) $122.94
- KRYSTEXXA (Biological) $120.88
- Velphoro (Drug) $120.36
- (7881) US Und (Device) $118.91
- ELIQUIS (Drug) $118.87
- DOVATO (Drug) $114.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Tulsa
Dr. Sunil Agrawal, Md, MD
Nephrology — Payments: $49,258
Nephrology $49,258
Pranay Kathuria, Md Facp, MD FACP
Nephrology — Payments: $18,785
Nephrology $18,785
Diptesh Gupta, M.d, M.D
Nephrology — Payments: $12,582
Nephrology $12,582
Kevin Fu, Md, MD
Nephrology — Payments: $12,272
Nephrology $12,272
Ms. Janet Russell, Md, MD
Nephrology — Payments: $12,209
Nephrology $12,209
Bobby Muthalaly, Md, MD
Nephrology — Payments: $11,730
Nephrology $11,730